GoodRx Holdings

GDRX-Q

Analysis and Opinions about GDRX-Q

Signal
Opinion
Expert
BUY WEAKNESS
BUY WEAKNESS
October 6, 2020
He's been a huge fan of this company, but what price to enter? Now, it's way too high. You gotta wait.
Show full opinionHide full opinion
GoodRx Holdings (GDRX-Q)
October 6, 2020
He's been a huge fan of this company, but what price to enter? Now, it's way too high. You gotta wait.
BUY WEAKNESS
BUY WEAKNESS
September 29, 2020
Allan Tong’s Discover Picks Trading on the Nasdaq, GoodRX IPO'd last week and doubled its asking price on day one. Then again, a few other tech IPO's also hit the markets recently and they too doubled. GoodRx offers a drug-comparison tool, indicating where to buy your prescriptions at the cheapest price. There's less need for that in Canada, which is blessed with universal healthcare, but can save thousands for the typical American. Read Uber Stock and Splunk Stock: 3 More Exciting Top Tech Stocks to Watch for our full analysis.
Show full opinionHide full opinion
GoodRx Holdings (GDRX-Q)
September 29, 2020
Allan Tong’s Discover Picks Trading on the Nasdaq, GoodRX IPO'd last week and doubled its asking price on day one. Then again, a few other tech IPO's also hit the markets recently and they too doubled. GoodRx offers a drug-comparison tool, indicating where to buy your prescriptions at the cheapest price. There's less need for that in Canada, which is blessed with universal healthcare, but can save thousands for the typical American. Read Uber Stock and Splunk Stock: 3 More Exciting Top Tech Stocks to Watch for our full analysis.
PARTIAL BUY
PARTIAL BUY
September 23, 2020

IPO'd today and he likes this company. It's a prescription drug comparison tool, telling you the cheapest place to buy your meds in your area with an app. The company has now expanded into a telemedicine platform, a hot business now during Covid. Originally, it was priced around $24, then raised to $33, and today closed at $50.50. It has excellent financials in a business that's fast-growing. Also, it's driving medical costs for consumers down (in American's pricey, nightmarish healthcare system) and faces few competitors. It saves Americans money on drugs, he stresses. He uses their app himself and it has saved him $50K last year in meds. It had 48% revenue growth in first half-2020. Since 2016, compound annual growth has been 57%. They're profitable, with earnings topping $55 million in first half-2020 vs. $31 million first-half 2019, or 77% earnings growth. Massive. GoodRX is the most downloaded medical app on Google and Apple for the last three years. Only negative: their user count dipped in Q2 because of Covid lockdown. Problem is with today's close, it trades at 30x sales (not earnings) (To compare, Apple trades at 30x earnings.) Also, GoodRx's earnings remain small. He expects them to keep reporting spectacular earnings, and GoodRx's largest VC investor, Silverlight, bought $100 million in shares in today's IPO (usually, the VC cashes out during the IPO). Nibble at this now, but ideally would by in the $30s.

Show full opinionHide full opinion
GoodRx Holdings (GDRX-Q)
September 23, 2020

IPO'd today and he likes this company. It's a prescription drug comparison tool, telling you the cheapest place to buy your meds in your area with an app. The company has now expanded into a telemedicine platform, a hot business now during Covid. Originally, it was priced around $24, then raised to $33, and today closed at $50.50. It has excellent financials in a business that's fast-growing. Also, it's driving medical costs for consumers down (in American's pricey, nightmarish healthcare system) and faces few competitors. It saves Americans money on drugs, he stresses. He uses their app himself and it has saved him $50K last year in meds. It had 48% revenue growth in first half-2020. Since 2016, compound annual growth has been 57%. They're profitable, with earnings topping $55 million in first half-2020 vs. $31 million first-half 2019, or 77% earnings growth. Massive. GoodRX is the most downloaded medical app on Google and Apple for the last three years. Only negative: their user count dipped in Q2 because of Covid lockdown. Problem is with today's close, it trades at 30x sales (not earnings) (To compare, Apple trades at 30x earnings.) Also, GoodRx's earnings remain small. He expects them to keep reporting spectacular earnings, and GoodRx's largest VC investor, Silverlight, bought $100 million in shares in today's IPO (usually, the VC cashes out during the IPO). Nibble at this now, but ideally would by in the $30s.

COMMENT
COMMENT
September 23, 2020
It IPO'd today and doubled its asking price.
Show full opinionHide full opinion
GoodRx Holdings (GDRX-Q)
September 23, 2020
It IPO'd today and doubled its asking price.
Showing 1 to 4 of 4 entries
  • «
  • 1
  • »

GoodRx Holdings(GDRX-Q) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 3

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 3

Stockchase rating for GoodRx Holdings is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

GoodRx Holdings(GDRX-Q) Frequently Asked Questions

What is GoodRx Holdings stock symbol?

GoodRx Holdings is a American stock, trading under the symbol GDRX-Q on the NASDAQ (GDRX). It is usually referred to as NASDAQ:GDRX or GDRX-Q

Is GoodRx Holdings a buy or a sell?

In the last year, 3 stock analysts published opinions about GDRX-Q. 3 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is BUY on WEAKNESS. Read the latest stock experts' ratings for GoodRx Holdings.

Is GoodRx Holdings a good investment or a top pick?

GoodRx Holdings was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for GoodRx Holdings.

Why is GoodRx Holdings stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is GoodRx Holdings worth watching?

3 stock analysts on Stockchase covered GoodRx Holdings In the last year. It is a trending stock that is worth watching.

What is GoodRx Holdings stock price?

On 2020-10-30, GoodRx Holdings (GDRX-Q) stock closed at a price of $48.39.